Correlation between SARS-CoV-2 and ebola

Detalhes bibliográficos
Autor(a) principal: Pacheco, Nágila Iane
Data de Publicação: 2021
Outros Autores: Mendes, Luiza Aragão Paiva Pires Ferreira, Carneiro, Gabriel de Sousa, Sousa, Mariana Pacheco de, Sousa , Jucilene da Silva, Vasconcelos , Ian Carlos Cavalcante, Oliveira, Bruna Ellen Ribeiro de, Azevedo, Bruna da Silva, Rodrigues, Isabelle Vasconcelos, Lira, Adryana Ryta Ribeiro Sousa, Silva, Jorge Davi de Sousa e, Machado, Fernando Henrique Lima Sa, Bezerra, Jordianne Thamires Rodrigues, Silva, Veronildes de Sousa e
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/23772
Resumo: Introduction: The World Health Organization in 2020 declared the SARS-CoV-2 pandemic, which has high transmissibility causing a fatal acute respiratory syndrome. Furthermore, a rare and deadly disease, in addition to the above mentioned, proven by a virus is Ebola in primates (including man), which constitutes the most deadly and disseminated disease in global outbreaks. Objective: to establish a comparison between coronavirus and Ebola with a focus on mortality and lethality. Methodology: an integrative literature review using online databases such as: BVS, SCIELO, PUBMED, MEDLINE, WHO, IDRC, MS, CDC. Results and Discussions: In 2020, the 10th Ebola outbreak occurred and the 2nd largest since its discovery in 1976, 3,470 cases were reported. Currently, in 2021, according to Epidemiological Week (SE) 43, on October 30, 246,407,251 cases of COVID-19 have been confirmed in the world. Comparing the coronavirus, which has a fatality rate of 6.1% of infected people, with the threat of the Ebola virus, covering 90%, it is considered more aggravating, as it quickly causes the deaths of the sick. Conclusion: Thus, COVID-19 and Ebola are viruses that threaten global public health, due to their high rates of morbidity and mortality. However, it is necessary to follow the protocols and recommendations of the World Health Organization in the control and prevention of diseases.
id UNIFEI_239d2509be634d84a6cb0b19b700defc
oai_identifier_str oai:ojs.pkp.sfu.ca:article/23772
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Correlation between SARS-CoV-2 and ebolaCorrelación entre SARS-CoV-2 y ebolaCorrelação entre SARS-CoV-2 e o ebolaLetalidadeCOVID-19SARS-CoV-2Ebolavirus.LetalidadCOVID-19SARS-CoV-2Ebolavirus.LethalityCOVID-19SARS-CoV-2Ebolavirus.Introduction: The World Health Organization in 2020 declared the SARS-CoV-2 pandemic, which has high transmissibility causing a fatal acute respiratory syndrome. Furthermore, a rare and deadly disease, in addition to the above mentioned, proven by a virus is Ebola in primates (including man), which constitutes the most deadly and disseminated disease in global outbreaks. Objective: to establish a comparison between coronavirus and Ebola with a focus on mortality and lethality. Methodology: an integrative literature review using online databases such as: BVS, SCIELO, PUBMED, MEDLINE, WHO, IDRC, MS, CDC. Results and Discussions: In 2020, the 10th Ebola outbreak occurred and the 2nd largest since its discovery in 1976, 3,470 cases were reported. Currently, in 2021, according to Epidemiological Week (SE) 43, on October 30, 246,407,251 cases of COVID-19 have been confirmed in the world. Comparing the coronavirus, which has a fatality rate of 6.1% of infected people, with the threat of the Ebola virus, covering 90%, it is considered more aggravating, as it quickly causes the deaths of the sick. Conclusion: Thus, COVID-19 and Ebola are viruses that threaten global public health, due to their high rates of morbidity and mortality. However, it is necessary to follow the protocols and recommendations of the World Health Organization in the control and prevention of diseases.Introducción: La Organización Mundial de la Salud en 2020 declaró la pandemia del SARS-CoV-2, que tiene una alta transmisibilidad y causa un síndrome respiratorio agudo fatal. Además, una enfermedad rara y mortal, además de las mencionadas anteriormente, probada por un virus es el Ébola en primates (incluido el hombre), que constituye la enfermedad más mortal y diseminada en los brotes mundiales. Objetivo: establecer una comparación entre coronavirus y ébola con enfoque en mortalidad y letalidad. Metodología: revisión integradora de la literatura utilizando bases de datos en línea como: BVS, SCIELO, PUBMED, MEDLINE, OMS, IDRC, MS, CDC. Resultados y discusiones: En 2020, ocurrió el décimo brote de ébola y el segundo más grande desde su descubrimiento en 1976, se reportaron 3.470 casos. Actualmente, en 2021, según la Semana Epidemiológica (SE) 43, el 30 de octubre se han confirmado 246.407.251 casos de COVID-19 en el mundo. Comparando el coronavirus, que tiene una tasa de letalidad del 6,1% de las personas infectadas, con la amenaza del virus del Ébola, que cubre el 90%, se considera más agravante, ya que provoca rápidamente la muerte de los enfermos. Conclusión: Así, el COVID-19 y el Ébola son virus que amenazan la salud pública mundial, debido a sus altas tasas de morbilidad y mortalidad. Sin embargo, es necesario seguir los protocolos y recomendaciones de la Organización Mundial de la Salud en el control y prevención de enfermedades.Introdução: A Organização Mundial de Saúde em 2020 declarou a pandemia do SARS-CoV-2, que apresenta alta transmissibilidade causando uma síndrome respiratória aguda fatal. Outrossim, uma doença rara e mortal, além do citado a cima, provada por um vírus é o do Ebola em primatas (incluído o homem), constituem como mais mortífero e disseminado nos surtos globais. Objetivo: estabelecer a comparação entre o coronavirus e o ebola com foco na mortalidade e letalidade. Metodologia: uma revisão integrativa da literatura, utilizando bancos de dados online como: BVS, SCIELO, PUBMED, MEDLINE, WHO, IDRC, MS, CDC. Resultado e Discussões: Em 2020, ocorreu o 10° surto de Ebola e a 2° maior desde sua descoberta em 1976, notificou-se 3.470 casos. Atualmente em 2021, conforme a Semana Epidemiológica (SE) 43, em 30 de outubro, confirmou-se 246.407.251 casos de COVID-19 no mundo. Comparando o coronavírus, que possui sua letalidade de 6,1% das pessoas eivadas, com a ameaça do Ebola vírus, abrangendo 90%, considera-se mais agravante, por ocasionar rapidamente as mortes dos enfermos. Conclusão: Dessa forma, a COVID-19 e o Ebola são vírus de ameaças a saúde pública global, devido as suas elevadas taxas de morbidade e mortalidade. Contudo, carece seguir os protocolos e as recomendações da Organização Mundial da Saúde no controle e prevenção das enfermidades.Research, Society and Development2021-12-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2377210.33448/rsd-v10i16.23772Research, Society and Development; Vol. 10 No. 16; e294101623772Research, Society and Development; Vol. 10 Núm. 16; e294101623772Research, Society and Development; v. 10 n. 16; e2941016237722525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/23772/20934Copyright (c) 2021 Nágila Iane Pacheco; Luiza Aragão Paiva Pires Ferreira Mendes; Gabriel de Sousa Carneiro; Mariana Pacheco de Sousa; Jucilene da Silva Sousa ; Ian Carlos Cavalcante Vasconcelos ; Bruna Ellen Ribeiro de Oliveira; Bruna da Silva Azevedo; Isabelle Vasconcelos Rodrigues; Adryana Ryta Ribeiro Sousa Lira; Jorge Davi de Sousa e Silva; Fernando Henrique Lima Sa Machado; Jordianne Thamires Rodrigues Bezerra; Veronildes de Sousa e Silvahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessPacheco, Nágila IaneMendes, Luiza Aragão Paiva Pires Ferreira Carneiro, Gabriel de SousaSousa, Mariana Pacheco de Sousa , Jucilene da Silva Vasconcelos , Ian Carlos Cavalcante Oliveira, Bruna Ellen Ribeiro de Azevedo, Bruna da Silva Rodrigues, Isabelle Vasconcelos Lira, Adryana Ryta Ribeiro Sousa Silva, Jorge Davi de Sousa e Machado, Fernando Henrique Lima Sa Bezerra, Jordianne Thamires Rodrigues Silva, Veronildes de Sousa e2021-12-20T11:03:07Zoai:ojs.pkp.sfu.ca:article/23772Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:42:32.124789Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Correlation between SARS-CoV-2 and ebola
Correlación entre SARS-CoV-2 y ebola
Correlação entre SARS-CoV-2 e o ebola
title Correlation between SARS-CoV-2 and ebola
spellingShingle Correlation between SARS-CoV-2 and ebola
Pacheco, Nágila Iane
Letalidade
COVID-19
SARS-CoV-2
Ebolavirus.
Letalidad
COVID-19
SARS-CoV-2
Ebolavirus.
Lethality
COVID-19
SARS-CoV-2
Ebolavirus.
title_short Correlation between SARS-CoV-2 and ebola
title_full Correlation between SARS-CoV-2 and ebola
title_fullStr Correlation between SARS-CoV-2 and ebola
title_full_unstemmed Correlation between SARS-CoV-2 and ebola
title_sort Correlation between SARS-CoV-2 and ebola
author Pacheco, Nágila Iane
author_facet Pacheco, Nágila Iane
Mendes, Luiza Aragão Paiva Pires Ferreira
Carneiro, Gabriel de Sousa
Sousa, Mariana Pacheco de
Sousa , Jucilene da Silva
Vasconcelos , Ian Carlos Cavalcante
Oliveira, Bruna Ellen Ribeiro de
Azevedo, Bruna da Silva
Rodrigues, Isabelle Vasconcelos
Lira, Adryana Ryta Ribeiro Sousa
Silva, Jorge Davi de Sousa e
Machado, Fernando Henrique Lima Sa
Bezerra, Jordianne Thamires Rodrigues
Silva, Veronildes de Sousa e
author_role author
author2 Mendes, Luiza Aragão Paiva Pires Ferreira
Carneiro, Gabriel de Sousa
Sousa, Mariana Pacheco de
Sousa , Jucilene da Silva
Vasconcelos , Ian Carlos Cavalcante
Oliveira, Bruna Ellen Ribeiro de
Azevedo, Bruna da Silva
Rodrigues, Isabelle Vasconcelos
Lira, Adryana Ryta Ribeiro Sousa
Silva, Jorge Davi de Sousa e
Machado, Fernando Henrique Lima Sa
Bezerra, Jordianne Thamires Rodrigues
Silva, Veronildes de Sousa e
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Pacheco, Nágila Iane
Mendes, Luiza Aragão Paiva Pires Ferreira
Carneiro, Gabriel de Sousa
Sousa, Mariana Pacheco de
Sousa , Jucilene da Silva
Vasconcelos , Ian Carlos Cavalcante
Oliveira, Bruna Ellen Ribeiro de
Azevedo, Bruna da Silva
Rodrigues, Isabelle Vasconcelos
Lira, Adryana Ryta Ribeiro Sousa
Silva, Jorge Davi de Sousa e
Machado, Fernando Henrique Lima Sa
Bezerra, Jordianne Thamires Rodrigues
Silva, Veronildes de Sousa e
dc.subject.por.fl_str_mv Letalidade
COVID-19
SARS-CoV-2
Ebolavirus.
Letalidad
COVID-19
SARS-CoV-2
Ebolavirus.
Lethality
COVID-19
SARS-CoV-2
Ebolavirus.
topic Letalidade
COVID-19
SARS-CoV-2
Ebolavirus.
Letalidad
COVID-19
SARS-CoV-2
Ebolavirus.
Lethality
COVID-19
SARS-CoV-2
Ebolavirus.
description Introduction: The World Health Organization in 2020 declared the SARS-CoV-2 pandemic, which has high transmissibility causing a fatal acute respiratory syndrome. Furthermore, a rare and deadly disease, in addition to the above mentioned, proven by a virus is Ebola in primates (including man), which constitutes the most deadly and disseminated disease in global outbreaks. Objective: to establish a comparison between coronavirus and Ebola with a focus on mortality and lethality. Methodology: an integrative literature review using online databases such as: BVS, SCIELO, PUBMED, MEDLINE, WHO, IDRC, MS, CDC. Results and Discussions: In 2020, the 10th Ebola outbreak occurred and the 2nd largest since its discovery in 1976, 3,470 cases were reported. Currently, in 2021, according to Epidemiological Week (SE) 43, on October 30, 246,407,251 cases of COVID-19 have been confirmed in the world. Comparing the coronavirus, which has a fatality rate of 6.1% of infected people, with the threat of the Ebola virus, covering 90%, it is considered more aggravating, as it quickly causes the deaths of the sick. Conclusion: Thus, COVID-19 and Ebola are viruses that threaten global public health, due to their high rates of morbidity and mortality. However, it is necessary to follow the protocols and recommendations of the World Health Organization in the control and prevention of diseases.
publishDate 2021
dc.date.none.fl_str_mv 2021-12-12
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/23772
10.33448/rsd-v10i16.23772
url https://rsdjournal.org/index.php/rsd/article/view/23772
identifier_str_mv 10.33448/rsd-v10i16.23772
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/23772/20934
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 10 No. 16; e294101623772
Research, Society and Development; Vol. 10 Núm. 16; e294101623772
Research, Society and Development; v. 10 n. 16; e294101623772
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052809769648128